NCT05751174View on ClinicalTrials.gov

Determination of Nerve Growth Factor (NGF) Expression in Pediatric Patients With Severe Burns: a Pilot Study

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

May 26, 2022

Study Completion Date

August 30, 2022

Conditions
Burns
Interventions
OTHER

pediatric patients affected by severe burns

All patients admitted to the pediatric intensive care unit affected by severe burns involving more than 10% of the body surface will be enrolled.

Trial Locations (1)

00168

Giorgio Conti, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05751174 - Determination of Nerve Growth Factor (NGF) Expression in Pediatric Patients With Severe Burns: a Pilot Study | Biotech Hunter | Biotech Hunter